Including obesity drugs among the WHO’s essential medicines could have great significance for that population. Experts say that adding HIV drugs to the list in 2002 helped to make them much more ...

WeightWatchers said on Tuesday it would offer a compounded version of Novo Nordisk's popular obesity drug Wegovy as part of ...

The cost of taking weekly injections of popular anti-obesity medications liraglutide (Saxenda) or semaglutide (Wegovy) ...

Semaglutide, the underlying drug marketed as Ozempic and Wegovy, works by mimicking a hormone that triggers the body to feel ...

Ilant estimates that behavioral therapy can help many people lose up to 5% of their weight, anti-obesity medications can help ...

Novo Nordisk’s CEO Lars Fruergaard Jørgensen faced tough congressional scrutiny over the high prices of its obesity ...

The race to supply obesity drugs is so competitive that one early-stage startup is already striking a deal for commercial ...

Shares in Hims & Hers Health fell after the U.S. Food and Drug Administration said Eli Lilly's obesity and diabetes ... loss and diabetes drugs from its shortage list late Wednesday, meaning ...

Eli Lilly’s juggernaut diabetes and obesity drugs Mounjaro and Zepbound have been erased from the FDA’s shortage list, freeing the company from competing with compounding pharmacies that have ...

Recommended Reading Investors put $400M into biotech licensing obesity drugs from China In a year when metabolic diseases have drawn major investor interest, the newest player has big-name backing ...

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately ...